The University of Connecticut spinout has received $500,000 from state-owned firm Connecticut Innovations, and will now advance R&D on its protein-coated implant for eye diseases.
LambdaVision, a US-based ophthalmology developer spun out from University of Connecticut (UConn), has obtained $500,000 in series A funding from state government-owned VC firm Connecticut Innovations.
Connecticut Innovations invested through its Connecticut Bioscience Innovation Fund, a $200m vehicle that supports Connecticut-based startups in the bioscience, cleantech, computing, photonics and advanced materials segments.
Founded in 2009, LambdaVision has developed a protein-coated implant that can be positioned behind the retina. The protein, bacteriorhodopsin, is light-activated and could potentially repair vision loss from…
